Clinical Trials Browser

Phase 2 × Myeloproliferative Disorders × Ascorbic Acid × Clear all

NCT03397173 2021-08-11

TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid

Phase 2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute